Skip to content

Leap Motion Based Gamefication Exercises in the Individuals With Systemic Sclerosis

The Development and Investigation of Effectiveness of Leap Motion Based Gamefication Exercises in Hand Rehabilitation of the Individuals With Systemic Sclerosis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05821335
Enrollment
32
Registered
2023-04-20
Start date
2023-05-30
Completion date
2024-05-30
Last updated
2023-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hand Rheumatism, Physiotherapy, Rehabilitation, Rheumatology, Scleroderma, Systemic, Video Games

Keywords

Scleroderma, Systemic, Hand therapy, Therapy, Computer-Assisted

Brief summary

Leap Motion Based Gamefication Exercises in the Individuals With Systemic Sclerosis

Detailed description

The aim of this project is to develop Leap Motion Sensor-assisted rehabilitation games that can be easily applied in hand rehabilitation in individuals with SSc, motivating, directing to the right exercise, providing therapeutic evaluation and feedback during the game, and comparing the effectiveness of these rehabilitation games with traditional rehabilitation applications.

Interventions

OTHERLeap motion assisted rehabilitation

Hand Therapy via leap motion sensor

Hand Therapy by physiotherapist via traditional methods

Sponsors

Istanbul University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Assessment and treatment will be done by different investigators.

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Having the ability to adapt to exercises * Not having any diagnosed cardiac or orthopedic disease that may prevent the application of assessment methods

Exclusion criteria

* Having a diagnosis of juvenile-onset SSc * Having a history of neurological disease or trauma that will affect hand functions * Receiving another treatment, such as intra-articular injection, surgery, that may affect hand rehabilitation in the last 6 months * Having systemic involvement that may affect the treatment process or activities of daily living

Design outcomes

Primary

MeasureTime frameDescription
modified Hand Mobility in Scleroderma (mHAMIS)change from baseline at 5 weeksHand Mobility in Scleroderma is a hand function test developed for adults who have systemic sclerosis. HAMIS consists of 9 items designed to measure all movements assessed in an ordinary range of motion-measured hand test. Each item is graded on a 0-3 scale, where 0 corresponds to normal function and 3 denotes that the individual is unable to perform the item. Each hand is assessed separately. The total score of HAMIS for each hand is 370 Sandqvist and Eklund Vol. 13, No. 6, December 2000 27, which represents a high degree of dysfunction.

Secondary

MeasureTime frameDescription
Finger Joint Range of Motionchange from baseline at 5 weeksThe patients will be asked to close their fingers tightly and the distance between the pulp of the 2nd, 3rd, 4th, and 5th finger - distal palmar line (PP-DPD) will be measured in cm with the help of a ruler. Dominant and nondominant hand total scores will be calculated by summing the values found for the fingers of each hand separately.
Grip Strengthchange from baseline at 5 weeksA hand dynamometer will be used. For measurements, patients will be asked to make a maximally voluntary grip while sitting, elbow flexed to 90 degrees, wrist in semi-pronation with thumb pointing up. Measurements on the sick and healthy hand will be made 3 times in a row, and the average values will be recorded in kilograms (kg). Finger grip will be evaluated with a pinchmeter in three different positions (lateral, palmar, fingertip).
Skin Hardnesschange from baseline at 5 weeksSkin hardness will be measured with a durometer. Although the durometer is a device designed to measure non-biomaterial surface hardness, it is used clinically to evaluate sclerosis. Measurements will be made on the dorsal surface of the third finger, midphalanx, dorsum of the hand, palmar and dorsal aspects of the forearm.
Purdue Pegboard Testchange from baseline at 5 weeksPurdue Pegboard Test will be used to evaluate hand functions. This test is an objective and standardized test that is frequently used in practice to evaluate functional hand use. The test will be preferred because of its advantages in demonstrating the functional activities and ability of the hand and its ease of use. The patient will be asked to perform the test activities first with the dominant hand, then with the non-dominant hand in 30 seconds, and using both hands in 60 seconds. Scoring will be based on the number of successfully placed pins.

Contacts

Primary ContactTUGBA CIVI KARAASLAN, PhD
tugba.civi@iuc.edu.tr+905343855606

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026